FR2267773B1 - - Google Patents

Info

Publication number
FR2267773B1
FR2267773B1 FR7511796A FR7511796A FR2267773B1 FR 2267773 B1 FR2267773 B1 FR 2267773B1 FR 7511796 A FR7511796 A FR 7511796A FR 7511796 A FR7511796 A FR 7511796A FR 2267773 B1 FR2267773 B1 FR 2267773B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7511796A
Other languages
French (fr)
Other versions
FR2267773A1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EIDP Inc
Original Assignee
EI Du Pont de Nemours and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EI Du Pont de Nemours and Co filed Critical EI Du Pont de Nemours and Co
Publication of FR2267773A1 publication Critical patent/FR2267773A1/fr
Application granted granted Critical
Publication of FR2267773B1 publication Critical patent/FR2267773B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/46—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
    • C07D333/48—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D331/00—Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
    • C07D331/04—Four-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7511796A 1974-04-17 1975-04-16 Expired FR2267773B1 (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46169974A 1974-04-17 1974-04-17
US05/555,307 US4009847A (en) 1974-04-17 1975-03-11 1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents

Publications (2)

Publication Number Publication Date
FR2267773A1 FR2267773A1 (enExample) 1975-11-14
FR2267773B1 true FR2267773B1 (enExample) 1978-08-18

Family

ID=27040095

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7511796A Expired FR2267773B1 (enExample) 1974-04-17 1975-04-16

Country Status (21)

Country Link
US (1) US4009847A (enExample)
JP (1) JPS50148349A (enExample)
AR (1) AR208545A1 (enExample)
CA (1) CA1047042A (enExample)
CH (1) CH611292A5 (enExample)
DD (1) DD117223A5 (enExample)
DE (1) DE2516554A1 (enExample)
DK (1) DK164175A (enExample)
ES (1) ES436648A1 (enExample)
FI (1) FI751128A7 (enExample)
FR (1) FR2267773B1 (enExample)
GB (1) GB1461209A (enExample)
HU (1) HU173052B (enExample)
IE (1) IE41143B1 (enExample)
IL (1) IL47095A (enExample)
LU (1) LU72306A1 (enExample)
NL (1) NL7504570A (enExample)
NO (1) NO144071C (enExample)
PH (1) PH11722A (enExample)
SE (1) SE417965B (enExample)
YU (1) YU96075A (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156738A (en) * 1977-10-07 1979-05-29 E. I. Du Pont De Nemours And Company Ureidonitriles useful as antihypertensives
US6187799B1 (en) * 1997-05-23 2001-02-13 Onyx Pharmaceuticals Inhibition of raf kinase activity using aryl ureas
US6344476B1 (en) * 1997-05-23 2002-02-05 Bayer Corporation Inhibition of p38 kinase activity by aryl ureas
US7329670B1 (en) 1997-12-22 2008-02-12 Bayer Pharmaceuticals Corporation Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
US20080300281A1 (en) * 1997-12-22 2008-12-04 Jacques Dumas Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
US7517880B2 (en) * 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
US20080269265A1 (en) * 1998-12-22 2008-10-30 Scott Miller Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
WO2000042012A1 (en) 1999-01-13 2000-07-20 Bayer Corporation φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
US7928239B2 (en) 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
IL144144A0 (en) * 1999-01-13 2002-05-23 Bayer Ag Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
US7351834B1 (en) 1999-01-13 2008-04-01 Bayer Pharmaceuticals Corporation ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7235576B1 (en) 2001-01-12 2007-06-26 Bayer Pharmaceuticals Corporation Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7371763B2 (en) * 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
ES2393900T3 (es) * 2001-12-03 2012-12-28 Bayer Healthcare Llc Compuestos de aril-urea en combinación con otros agentes citostáticos o citotóxicos para tratamiento de cánceres humanos
US20080108672A1 (en) * 2002-01-11 2008-05-08 Bernd Riedl Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
WO2003068229A1 (en) 2002-02-11 2003-08-21 Bayer Pharmaceuticals Corporation Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
AU2003210969A1 (en) * 2002-02-11 2003-09-04 Bayer Corporation Aryl ureas with raf kinase and angiogenesis inhibiting activity
SI1478358T1 (sl) * 2002-02-11 2013-09-30 Bayer Healthcare Llc Sorafenib tozilat za zdravljenje bolezni, značilnih po abnormalni angiogenezi
PT1580188E (pt) * 2002-02-11 2012-01-25 Bayer Healthcare Llc Aril-ureias como inibidores de cinases
US7557129B2 (en) 2003-02-28 2009-07-07 Bayer Healthcare Llc Cyanopyridine derivatives useful in the treatment of cancer and other disorders
JP4860474B2 (ja) * 2003-05-20 2012-01-25 バイエル、ファーマシューテイカルズ、コーポレイション Ｐｄｇｆｒによって仲介される病気のためのジアリール尿素
CL2004001834A1 (es) * 2003-07-23 2005-06-03 Bayer Pharmaceuticals Corp Compuesto 4-{4-[3-(4-cloro-3-trifluorometilfenil)-ureido]-3-fluorofenoxi}-piridin-2-metilamida, inhibidor de la raf, vegfr, p38 y pdgfr quinasas, sus sales; composiicon farmaceutica; combinacion farmaceutica; y su uso para tratar trastornos hiperprol
CN101010315A (zh) * 2004-04-30 2007-08-01 拜耳制药公司 用于治疗癌症的取代的吡唑基脲衍生物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH452475A (de) * 1965-05-20 1968-05-31 Bayer Ag Verfahren zum Färben und Bedrucken von synthetischem Textilmaterial mit Anthrachinonfarbstoffen

Also Published As

Publication number Publication date
US4009847A (en) 1977-03-01
CA1047042A (en) 1979-01-23
NO144071C (no) 1981-06-17
DD117223A5 (enExample) 1976-01-05
YU96075A (en) 1983-04-27
NL7504570A (nl) 1975-10-21
DE2516554A1 (de) 1975-10-30
SE417965B (sv) 1981-04-27
NO751351L (enExample) 1975-10-20
IE41143L (en) 1975-10-17
IL47095A0 (en) 1975-06-25
PH11722A (en) 1978-05-30
AU8013575A (en) 1976-10-21
ES436648A1 (es) 1977-08-01
FR2267773A1 (enExample) 1975-11-14
AR208545A1 (es) 1977-02-15
HU173052B (hu) 1979-02-28
FI751128A7 (enExample) 1975-10-18
IL47095A (en) 1978-03-10
LU72306A1 (enExample) 1976-03-17
IE41143B1 (en) 1979-10-24
GB1461209A (en) 1977-01-13
DK164175A (da) 1975-10-18
NO144071B (no) 1981-03-09
JPS50148349A (enExample) 1975-11-27
SE7503523L (sv) 1975-10-20
CH611292A5 (enExample) 1979-05-31

Similar Documents

Publication Publication Date Title
FR2267773B1 (enExample)
FI753656A7 (enExample)
FR2257946B1 (enExample)
FI316874A7 (enExample)
FR2258920B1 (enExample)
AU7891375A (enExample)
FI50592B (enExample)
DE2448935A1 (enExample)
DE2431847A1 (enExample)
CS176528B1 (enExample)
BG20042A1 (enExample)
BG19628A1 (enExample)
BG19996A1 (enExample)
BG19943A1 (enExample)
BG19893A1 (enExample)
BG19866A1 (enExample)
BG19999A1 (enExample)
BG19856A1 (enExample)
BG19813A1 (enExample)
BE836983A (enExample)
BG20149A1 (enExample)
BG19703A1 (enExample)
BG20224A1 (enExample)
BG19663A1 (enExample)
BG19639A1 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse